Literature DB >> 12080469

Regulation of c-myc stability by selective stress conditions and by MEKK1 requires aa 127-189 of c-myc.

Dania Alarcon-Vargas1, William P Tansey, Ze'ev Ronai.   

Abstract

C-myc availability is central for its ability to serve as a regulator of cell growth and death. Here we study the regulation of c-myc protein stability and identify domains of c-myc that are important for its stabilization in response to stress kinases activated following selective stress conditions. UV-irradiation elicited an increase in c-myc protein levels, which could be attenuated by inhibitors of stress kinases but also by actinomycin D-inhibitor of transcription. Inhibition of protein synthesis results in a noticeable decrease in c-myc levels, further pointing to the short half-life of the protein. However, in combination with tumor necrosis factor-alpha (TNF-alpha), cycloheximide efficiently increases steady-state levels of c-myc, suggesting that selective stress conditions are required to increase c-myc protein stability. Expression of MEKK1, an upstream regulator of protein kinases that has been implicated in mediating the response to diverse stress conditions, also results in an efficient increase in the half-life of c-myc protein. To map c-myc domains that are responsive to stress kinases, we monitored changes in the level of c-myc deletion mutants following MEKK1 expression. Of the seven c-myc deletion mutants analysed, the domain spanning amino acids 127-189 was found to be required for MEKK1-dependent increase in c-myc stability. In all, the present study identifies a novel domain that is important for the regulation of c-myc stability by stress kinases in response to selective stress conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080469     DOI: 10.1038/sj.onc.1205543

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

Authors:  Dylan M Glubb; Mel J Maranian; Kyriaki Michailidou; Karen A Pooley; Kerstin B Meyer; Siddhartha Kar; Saskia Carlebur; Martin O'Reilly; Joshua A Betts; Kristine M Hillman; Susanne Kaufmann; Jonathan Beesley; Sander Canisius; John L Hopper; Melissa C Southey; Helen Tsimiklis; Carmel Apicella; Marjanka K Schmidt; Annegien Broeks; Frans B Hogervorst; C Ellen van der Schoot; Kenneth Muir; Artitaya Lophatananon; Sarah Stewart-Brown; Pornthep Siriwanarangsan; Peter A Fasching; Matthias Ruebner; Arif B Ekici; Matthias W Beckmann; Julian Peto; Isabel dos-Santos-Silva; Olivia Fletcher; Nichola Johnson; Paul D P Pharoah; Manjeet K Bolla; Qin Wang; Joe Dennis; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Barbara Burwinkel; Frederik Marme; Rongxi Yang; Harald Surowy; Pascal Guénel; Thérèse Truong; Florence Menegaux; Marie Sanchez; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Anna González-Neira; Javier Benitez; M Pilar Zamora; Jose Ignacio Arias Perez; Hoda Anton-Culver; Susan L Neuhausen; Hermann Brenner; Aida Karina Dieffenbach; Volker Arndt; Christa Stegmaier; Alfons Meindl; Rita K Schmutzler; Hiltrud Brauch; Yon-Dschun Ko; Thomas Brüning; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Keitaro Matsuo; Hidemi Ito; Hiroji Iwata; Hideo Tanaka; Thilo Dörk; Natalia V Bogdanova; Sonja Helbig; Annika Lindblom; Sara Margolin; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Anna H Wu; Chiu-chen Tseng; David Van Den Berg; Daniel O Stram; Diether Lambrechts; Hui Zhao; Caroline Weltens; Erik van Limbergen; Jenny Chang-Claude; Dieter Flesch-Janys; Anja Rudolph; Petra Seibold; Paolo Radice; Paolo Peterlongo; Monica Barile; Fabio Capra; Fergus J Couch; Janet E Olson; Emily Hallberg; Celine Vachon; Graham G Giles; Roger L Milne; Catriona McLean; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Jacques Simard; Mark S Goldberg; France Labrèche; Martine Dumont; Soo Hwang Teo; Cheng Har Yip; Mee-Hoong See; Belinda Cornes; Ching-Yu Cheng; M Kamran Ikram; Vessela Kristensen; Wei Zheng; Sandra L Halverson; Martha Shrubsole; Jirong Long; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Saila Kauppila; Irene L Andrulis; Julia A Knight; Gord Glendon; Sandrine Tchatchou; Peter Devilee; Robert A E M Tollenaar; Caroline Seynaeve; Christi J Van Asperen; Montserrat García-Closas; Jonine Figueroa; Stephen J Chanock; Jolanta Lissowska; Kamila Czene; Daniel Klevebring; Hatef Darabi; Mikael Eriksson; Maartje J Hooning; Antoinette Hollestelle; John W M Martens; J Margriet Collée; Per Hall; Jingmei Li; Keith Humphreys; Xiao-Ou Shu; Wei Lu; Yu-Tang Gao; Hui Cai; Angela Cox; Simon S Cross; Malcolm W R Reed; William Blot; Lisa B Signorello; Qiuyin Cai; Mitul Shah; Maya Ghoussaini; Daehee Kang; Ji-Yeob Choi; Sue K Park; Dong-Young Noh; Mikael Hartman; Hui Miao; Wei Yen Lim; Anthony Tang; Ute Hamann; Diana Torres; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Suleeporn Sangrajrang; Valerie Gaborieau; Paul Brennan; James McKay; Curtis Olswold; Susan Slager; Amanda E Toland; Drakoulis Yannoukakos; Chen-Yang Shen; Pei-Ei Wu; Jyh-Cherng Yu; Ming-Feng Hou; Anthony Swerdlow; Alan Ashworth; Nick Orr; Michael Jones; Guillermo Pita; M Rosario Alonso; Nuria Álvarez; Daniel Herrero; Daniel C Tessier; Daniel Vincent; Francois Bacot; Craig Luccarini; Caroline Baynes; Shahana Ahmed; Catherine S Healey; Melissa A Brown; Bruce A J Ponder; Georgia Chenevix-Trench; Deborah J Thompson; Stacey L Edwards; Douglas F Easton; Alison M Dunning; Juliet D French
Journal:  Am J Hum Genet       Date:  2014-12-18       Impact factor: 11.025

2.  Network modeling of CDF treated pancreatic cancer cells reveals a novel c-myc-p73 dependent apoptotic mechanism.

Authors:  Asfar S Azmi; Shadan Ali; Sanjeev Banerjee; Bin Bao; Mai N Maitah; Subhash Padhye; Philip A Philip; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2011-07-26       Impact factor: 4.060

3.  Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.

Authors:  Wen-Bin Tsai; Isamu Aiba; Soo-yong Lee; Lynn Feun; Niramol Savaraj; Macus Tien Kuo
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

4.  Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation.

Authors:  Yeung-Tung Siu; Yick-Pang Ching; Dong-Yan Jin
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

Review 5.  Controlling transcription by destruction: the regulation of yeast Gcn4p stability.

Authors:  Stefan Irniger; Gerhard H Braus
Journal:  Curr Genet       Date:  2003-07-09       Impact factor: 3.886

6.  The PIM-2 kinase is an essential component of the ultraviolet damage response that acts upstream to E2F-1 and ATM.

Authors:  Shahar Zirkin; Ateret Davidovich; Jeremy Don
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

7.  Negative control of the Myc protein by the stress-responsive kinase Pak2.

Authors:  Zhongdong Huang; Jolinda A Traugh; J Michael Bishop
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  Inference of cell cycle-dependent proteolysis by laser scanning cytometry.

Authors:  Abhishek A Chakraborty; William P Tansey
Journal:  Exp Cell Res       Date:  2009-01-27       Impact factor: 3.905

9.  Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.

Authors:  Yan Long; Wen-Bin Tsai; Jeffrey T Chang; Marcos Estecio; Medhi Wangpaichitr; Naramol Savaraj; Lynn G Feun; Helen H W Chen; Macus Tien Kuo
Journal:  Oncotarget       Date:  2016-12-13

10.  Altering chemosensitivity by modulating translation elongation.

Authors:  Francis Robert; Marilyn Carrier; Svea Rawe; Samuel Chen; Scott Lowe; Jerry Pelletier
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.